Zenotech Laboratories Ltd

Zenotech_Lab.03 Dec 2024

Pharmaceuticals

₹

+0.16 (+0.21%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

Pharmaceuticals

Zenotech_Lab.03 Dec 2024

₹

+0.16 (+0.21%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
20-May-2017	R	17:22 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Zenotech Laboratories Ltd. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Zenotech Laboratories Ltd. (532039) RECORD DATE 02/06/2017 PURPOSE Issue of 17 (SEVENTEEN) equity shares of Rs. 10/- each on rights basis for cash at premium of Rs. 35/- per share for every 22 (TWENTY TWO) equity shares held. Ex-Right basis from Date & Sett. No. 01/06/2017 DR-043/2017-2018 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 31/05/2017)	02-Jun-2017	17:22
17-Oct-2024	BC	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial R	23-Oct-2024
23-Oct-2024	BC	Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Comp	23-Oct-2024
23-Aug-2024	BC	Intimation of 35th Annual General Meeting of the Company will be held on Friday, September 27, 2024 at 10:30 a.m. IST through Video Conferencing. Voting Results of 35th Annual General Meeting and	27-Sep-2024
18-Jul-2024	BC	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Resul	26-Jul-2024
17-May-2024	BC	Resignation of Chief Executive Officer ('Key Managerial Personnel') of Zenotech Laboratories Limited.	17-May-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)35

Ratio17:22

Book Closure

Record Date	Split Date	Purpose
23-Oct-2024	-	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial R
23-Oct-2024	-	Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Comp
27-Sep-2024	-	Intimation of 35th Annual General Meeting of the Company will be held on Friday, September 27, 2024 at 10:30 a.m. IST through Video Conferencing. Voting Results of 35th Annual General Meeting and
26-Jul-2024	-	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Resul
17-May-2024	-	Resignation of Chief Executive Officer ('Key Managerial Personnel') of Zenotech Laboratories Limited.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Zenotech Laboratories Ltd ₹76.77(+0.16/0.21%)	76.77	+0.16	468.53	15.97	79.97	5.03
Ambalal Sarabhai Enterprises Ltd ₹58.42(-0.30/-0.51%)	58.42	-0.30	447.69	43.29	50.80	9.93
Astrazeneca Pharma India Ltd ₹6,597.95(-114.70/-1.71%)	6,597.95	-114.70	16,494.88	37.49	128.14	24.28
Amrutanjan Health Care Ltd ₹749.60(+8.75/1.18%)	749.60	+8.75	2,167.14	24.54	45.60	7.28
Abbott India Ltd ₹28,443.65(+387.55/1.38%)	28,443.65	+387.55	60,442.76	21.64	47.05	17.17
Bliss GVS Pharma Ltd ₹163.60(-4.50/-2.68%)	163.60	-4.50	1,722.74	15.41	21.30	1.68

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	11.14	2.41	2.46	1.08	13.20
Net Cash from Operating Activities	11.82	20.66	17.67	5.74	11.38
Net Cash Used In Investing Activities	-21.15	-5.82	-1.84	-4.82	-20.79
Net Cash Used In Financing Activities	0.00	-6.11	-15.87	0.45	-2.70
Net Inc./Dec In Cash And Cash Equivalents	-9.33	8.73	-0.04	1.38	-12.11
Cash And Cash Equivalents At End Of The Year	1.82	11.14	2.41	2.46	1.08

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.84%

FII Shareholding

0.00%

DII Shareholding

0.99%

Public Shareholding

30.17%

**Promoter pledged shareholding 68.84%

About Zenotech Laboratories Ltd

Zenotech Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 468.53 crores. It has reported a sales of Rs. 8.75 crores and a net profit of Rs. 1.35 crores for the quarter ended December 2018. The company management includes Azadar Hussain Khan, Kavita Shah,Jignesh Anantray Goradia,Azadar Hussain Khan,Chintan Jitendra Shah,Abdul Gafoor Mohammad,JAGRUTI PRASHANT SHETH,Rakeshchandra Jagdishprasad Sinha (Zenotech Laboratories Ltd) among others.

Chairman

Azadar Hussain Khan

Registered office

S No 250-252 Turkapally Villag,Shameerpet Mandal RR District,Hyderabad,Telangana,500078

FAX :91-40-23480429

Background

Incorporation Year1989

Face Value₹10

Market Lot1